ASTRAZENECA PHARMA INDIA
Back to Income Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,716 Cr | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr | ₹814 Cr |
What is the latest Revenue of ASTRAZENECA PHARMA INDIA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,716 Cr |
| Mar2024 | ₹1,296 Cr |
| Mar2023 | ₹1,003 Cr |
| Mar2022 | ₹806 Cr |
| Mar2021 | ₹814 Cr |
How is Revenue of ASTRAZENECA PHARMA INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,716 Cr | 32.48 | |
| Mar2024 | ₹1,296 Cr | 29.17 | |
| Mar2023 | ₹1,003 Cr | 24.50 | |
| Mar2022 | ₹806 Cr | -0.98 | |
| Mar2021 | ₹814 Cr | - | |
Compare Revenue of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,528.5 Cr | -4.7% | -5.3% | 20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -4.7% |
-5.3% |
20.1% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses